Planet Fitness could be among the beneficiaries of the GLP-1 craze, according to Stifel.
Get this delivered to your inbox, and more info about our products and services.
The connection between weight loss drugs, jet fuel and the software sell-off explained.
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…
The investment firm initiated coverage of the biopharma stock at a outperform rating.
Thanks to its “best-in-class” status, the bank believes the company will be the winner from a growing GLP-1 patient base.
Shares of Planet Fitness plunged Thursday after the fitness company slashed its guidance and canceled planned price hikes.
Analyst Eric Sheridan upgraded the connected fitness company to a price target that suggests more than 61% potential upside.
